Ganaplacide (development codename KAF156) is a drug in development by Novartis for the purpose of treating malaria. It is a imidazolopiperazine derivative. It has shown activity against the Plasmodium falciparum and Plasmodium vivax forms of the malaria parasite.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.